The Bristol Myers Squibb Foundation

The Multinational Lung Cancer Control Program (MLCCP), our signature cancer program, is a global collaboration to improve awareness, knowledge, and access to care for unmet needs for lung cancer. We are developing grantee partnerships that build capacity and increase access to care.  

We have a steadfast commitment to be a leader in the wider pediatric community and improve global health for pediatric patients. Our work is aligned with innovative organizations, health systems and capacity-building initiatives focused on pediatric cancers, sickle cell disease and beta-thalassemia.

The Bristol Myers Squibb Foundation is advancing brain health by strengthening systems that support prevention, early identification, and access to care for people living with Serious Mental Illness (SMI). Through innovative programs that focus on workforce development and cross sector collaboration, we are building local capacity and expanding pathways to community-based care, particularly in medically underserved communities.

The Robert A. Winn Excellence in Clinical Trials Award Program addresses the priority of improving participation in clinical trials to drive better health outcomes in all communities to save more lives. By training the next generation of clinical trialists in the science of community engagement, we believe we can include more patients in clinical trials that match the epidemiology of the disease studied. Research areas include cancer, cardiovascular disease and neuropsychiatry.